BioAge Labs (BIOA) Return on Sales (2025 - 2026)
BioAge Labs (BIOA) posted Return on Sales of 0.08% for Q1 2026, down 56.93% sequentially from 0.05% in Q4 2025, and up 1.0% YoY from 0.08% in Q1 2025.
BioAge Labs (BIOA) Return on Sales (2025 - 2026) Analysis & Trends
BioAge Labs has reported Return on Sales for 2 years, with the latest figure at 0.08% in Q1 2026.
- Quarterly Return on Sales rose 1.0% year-over-year to 0.08% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.09% (up 89.0% YoY) and the FY2025 annual result came in at 0.14%, changed N/A from the prior year.
- Return on Sales fell to 0.08% in Q1 2026 per BIOA's latest filing, from 0.05% in the prior quarter.
- Over five years, Return on Sales peaked at 0.05% in Q4 2025 and troughed at 0.14% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | BioAge Labs | 434.04 Mn | 434.04 Mn | -14.23 Mn | -0.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.64% |
| Mar 31, 2026 | -0.08% |
| Dec 31, 2025 | -0.05% |
| Sep 30, 2025 | -0.14% |
| Jun 30, 2025 | -0.11% |
| Mar 31, 2025 | -0.09% |